Malin Andersson

1998-2002 Department of Pharmaceutical Biosciences Uppsala University, Uppsala, Uppsala län, Sweden 
"Malin Andersson"
Mean distance: 17.2 (cluster 11)


Sign in to add mentor
Angela Cenci grad student 1998-2002 Uppsala
BETA: Related publications


You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Kononenko O, Bazov I, Watanabe H, et al. (2016) Opioid precursor protein isoform is targeted to the cell nuclei in the human brain. Biochimica Et Biophysica Acta
Bergman HM, Lundin E, Andersson M, et al. (2016) Quantitative mass spectrometry imaging of small-molecule neurotransmitters in rat brain tissue sections using nanospray desorption electrospray ionization. The Analyst
Karlsson O, Bergquist J, Andersson M. (2014) Quality measures of imaging mass spectrometry aids in revealing long-term striatal protein changes induced by neonatal exposure to the cyanobacterial toxin β-N-methylamino-L-alanine (BMAA). Molecular & Cellular Proteomics : McP. 13: 93-104
Ljungdahl A, Hanrieder J, Bergquist J, et al. (2013) Analysis of neuropeptides by MALDI imaging mass spectrometry. Methods in Molecular Biology (Clifton, N.J.). 1023: 121-36
Hanrieder J, Ekegren T, Andersson M, et al. (2013) MALDI imaging of post-mortem human spinal cord in amyotrophic lateral sclerosis. Journal of Neurochemistry. 124: 695-707
Karlsson O, Berg AL, Lindström AK, et al. (2012) Neonatal exposure to the cyanobacterial toxin BMAA induces changes in protein expression and neurodegeneration in adult hippocampus. Toxicological Sciences : An Official Journal of the Society of Toxicology. 130: 391-404
Hanrieder J, Ljungdahl A, Andersson M. (2012) MALDI imaging mass spectrometry of neuropeptides in Parkinson's disease. Journal of Visualized Experiments : Jove
Lindgren HS, Rylander D, Iderberg H, et al. (2011) Putaminal upregulation of FosB/ΔFosB-like immunoreactivity in Parkinson's disease patients with dyskinesia. Journal of Parkinson's Disease. 1: 347-57
Ljungdahl A, Hanrieder J, Fälth M, et al. (2011) Imaging mass spectrometry reveals elevated nigral levels of dynorphin neuropeptides in L-DOPA-induced dyskinesia in rat model of Parkinson's disease. Plos One. 6: e25653
Hanrieder J, Ljungdahl A, Fälth M, et al. (2011) L-DOPA-induced dyskinesia is associated with regional increase of striatal dynorphin peptides as elucidated by imaging mass spectrometry. Molecular & Cellular Proteomics : McP. 10: M111.009308
See more...